ATOSSA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
ATOSSA THERAPEUTICS, INC. (ATOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 1.30 million shares for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2013-08-14
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-06-30 was 699.94K shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-03-31 was 602.71K shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2012-12-31 was 428.00K shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2012 was 447.76K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2013-06-30 | 699.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 1.30M shares 10-Q · filed 2013-08-14 | 1.73M shares derived: sum of 3 quarters · filed 2013-08-14 | |
| 2013-03-31 | 602.71K shares 10-Q · filed 2013-05-15 | 1.03M shares derived: sum of 2 quarters · filed 2013-05-15 | ||
| 2012-12-31 | 428.00K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | 447.76K shares 10-K · filed 2013-03-28 | ||
| 2012-09-30 | 19.76K shares 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |